Company Filing History:
Years Active: 2024
Title: Florence Chery: Innovator in Cognitive Dysfunction Treatments
Introduction
Florence Chery is a prominent inventor based in Strasbourg, France. She has made significant contributions to the field of cognitive dysfunction treatments, holding 2 patents that focus on innovative compounds for therapeutic use.
Latest Patents
Her latest patents include "Substituted-N-heteroaryl compounds and uses thereof," which details activators of Kv3.1 and/or Kv3.2 channels. These activators are therapeutically useful in treating cognitive dysfunction and negative symptoms associated with central nervous system disorders such as schizophrenia, Alzheimer's disease, Tourette's syndrome, autism, dementia, and epilepsy. The patent emphasizes the importance of substituted N-heteroaryl compounds in these treatments. Another notable patent is "Substituted-pyridinyl compounds and uses thereof," which relates to compounds that enhance cognitive function and address negative symptoms linked to CNS disorders. This patent enables the manufacture of medicaments and compositions for therapy and prophylaxis of cognitive dysfunction.
Career Highlights
Florence Chery is currently associated with Bionomics Inc., where she continues her research and development in the field of cognitive health. Her work is pivotal in advancing therapeutic options for patients suffering from various CNS disorders.
Collaborations
She collaborates with notable colleagues, including Hamish Toop and Rajinder Singh, to further her research initiatives and enhance the impact of her inventions.
Conclusion
Florence Chery's innovative work in developing compounds for cognitive dysfunction treatments showcases her dedication to improving mental health therapies. Her contributions are vital in addressing the challenges faced by individuals with CNS disorders.